RIGI and infection: Compared to the endemic HCoVs, SARS-CoV-2 infection results in the marked accumulation of 5′ end svRNAs and reaches higher levels at later stages of infection; the threshold for RIG-I activation can then be achieved by overcoming the antagonistic ability of viral defense proteins, which in turn drives exuberant IFN production and multiple ISGs.